Editas Medicine Inc
F:8EM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Editas Medicine Inc
F:8EM
|
US |
|
THC Therapeutics Inc
OTC:THCT
|
US |
|
H
|
Heartland Financial USA Inc
F:1H4
|
US |
|
H
|
Homeland Security Corp
OTC:HSCC
|
US |
|
D
|
Dong A Eltek Co Ltd
KOSDAQ:088130
|
KR |
|
MKF Krasnyi Oktyabr' PAO
MOEX:KROT
|
RU |
|
S
|
SatrecInitiativeCo Ltd
KOSDAQ:099320
|
KR |
|
Greenidge Generation Holdings Inc
NASDAQ:VIP
|
US |
|
bebe stores inc
NYSE:BEBE
|
US |
|
Glucose Health Inc
OTC:GLUC
|
US |
|
Sakhalinenergo PAO
MOEX:SLEN
|
RU |
|
Freedom Bank of Virginia
OTC:FDVA
|
US |
|
A
|
Anonymous Intelligence Company Inc
OTC:ANICF
|
CA |
|
S
|
Sawnics Inc
KOSDAQ:088280
|
KR |
|
F
|
Fuel Tech Inc
F:FUE1
|
US |
Bankruptcy Probability
Editas Medicine Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Editas Medicine Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Editas Medicine Inc
NASDAQ:EDIT
|
431.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Editas Medicine Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Editas Medicine Inc has total debt of 48.2m USD. This includes both short-term (0 USD) and long-term (48.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
